Sibylla Biotech has appointed Usman Azam as CEO and Gianluca Fuggetta as CFO, expanding its executive team to accelerate the development of its novel protein folding interference technology targeting Cyclin D1 in cancer. Co-founder Lidia Pieri remains as COO, and Elena Ardini is promoted to Chief Scientific Officer. The leadership changes reflect Sibylla's progress in advancing its lead oncology program toward first-in-human clinical studies, aiming to unlock new therapeutic targets through a unique protein degradation approach. This strategy could potentially transform cancer treatment by targeting proteins previously considered undruggable.
Sibylla Biotech's executive team expansion and leadership appointments provide context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 13, 2026 14:12 WIB: Among 128 priced US health-sector stocks, 67 rose and 53 fell. Notable movers include ERAS at USD 15.44 with a -3.68% change and 100% buy order activity, XRAY at USD 8.51 down 3.62% with 0% sell orders and a typical hold time of 72 days, and ZBH at USD 92.12 up 3.34% with a typical hold time of 89 days.
Holafly has introduced the Ultra Plan, a new global eSIM subscription that offers unlimited mobile data alongside health and wellness services, including 24/7 medical messaging, mental health sessions, nutrition and fitness coaching, and veterinary a...
Investec Bank plc, acting as advisor and broker for Gooch & Housego plc, sold 2,013 ordinary shares at a price of 1,230 per share on October 12, 2026. This transaction was disclosed under the Takeover Code, indicating a client-serving capacity trade ...
Sveriges Riksbank announced an auction for certificates totaling 470 billion SEK with an interest rate of 1.75%, maturing on October 21, 2026. The bid and auction dates were October 13, 2026, with settlement on October 14. This auction is part of the...
Optimum Strategic Communications and Catalyst Advisors have launched an official Networking Event Guide for the Jefferies Global Healthcare Conference and London Life Sciences Week, held from November 15-20, 2026. The guide consolidates various recep...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed its trading activities on October 12, 2026. The bank purchased 153,297 ordinary shares at prices between 1094 and 1094.5, and sold 65,648 shares at prices between 1094 ...
